Biohaven Statistics
Total Valuation
Biohaven has a market cap or net worth of $2.44 billion. The enterprise value is $2.37 billion.
Important Dates
The last earnings date was Monday, March 3, 2025, before market open.
| Earnings Date | Mar 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohaven has 102.05 million shares outstanding. The number of shares has increased by 28.14% in one year.
| Current Share Class | 102.05M |
| Shares Outstanding | 102.05M |
| Shares Change (YoY) | +28.14% |
| Shares Change (QoQ) | +7.08% |
| Owned by Insiders (%) | 11.55% |
| Owned by Institutions (%) | 86.63% |
| Float | 84.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 33.42 |
| PB Ratio | 6.61 |
| P/TBV Ratio | 6.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.49 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -198.83% and return on invested capital (ROIC) is -118.92%.
| Return on Equity (ROE) | -198.83% |
| Return on Assets (ROA) | -96.85% |
| Return on Invested Capital (ROIC) | -118.92% |
| Return on Capital Employed (ROCE) | -189.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.31M |
| Employee Count | 256 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Biohaven has paid $735,000 in taxes.
| Income Tax | 735,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.67% in the last 52 weeks. The beta is 3.91, so Biohaven's price volatility has been higher than the market average.
| Beta (5Y) | 3.91 |
| 52-Week Price Change | -56.67% |
| 50-Day Moving Average | 34.80 |
| 200-Day Moving Average | 40.00 |
| Relative Strength Index (RSI) | 27.31 |
| Average Volume (20 Days) | 1,130,260 |
Short Selling Information
The latest short interest is 7.33 million, so 7.18% of the outstanding shares have been sold short.
| Short Interest | 7.33M |
| Short Previous Month | 8.62M |
| Short % of Shares Out | 7.18% |
| Short % of Float | 8.66% |
| Short Ratio (days to cover) | 6.64 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -874.21M |
| Pretax Income | -750.36M |
| Net Income | -846.42M |
| EBITDA | -866.36M |
| EBIT | -874.21M |
| Earnings Per Share (EPS) | -$9.28 |
Full Income StatementBalance Sheet
The company has $485.99 million in cash and $36.58 million in debt, giving a net cash position of $449.41 million or $4.40 per share.
| Cash & Cash Equivalents | 485.99M |
| Total Debt | 36.58M |
| Net Cash | 449.41M |
| Net Cash Per Share | $4.40 |
| Equity (Book Value) | 423.44M |
| Book Value Per Share | 4.18 |
| Working Capital | 384.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$582.45 million and capital expenditures -$4.05 million, giving a free cash flow of -$586.50 million.
| Operating Cash Flow | -582.45M |
| Capital Expenditures | -4.05M |
| Free Cash Flow | -586.50M |
| FCF Per Share | -$5.75 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |